Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -11,073 | N/A |
| Other Working Capital | 2,375 | N/A |
| Other Operating Activity | 1,721 | 0 |
| Operating Cash Flow | $-6,977 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -17 | N/A |
| Investing Cash Flow | $-17 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 2,094 | N/A |
| Other Financing Activity | 39,617 | 0 |
| Financing Cash Flow | $41,711 | $N/A |
| Beginning Cash Position | 152 | N/A |
| End Cash Position | 34,869 | N/A |
| Net Cash Flow | $34,717 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -6,977 | N/A |
| Capital Expenditure | -17 | N/A |
| Free Cash Flow | -6,994 | 0 |